Comparison of T-cell subsets' reconstitution after 12 months of highly active antiretroviral therapy initiated during early versus advanced states of HIV disease

Journal of Acquired Immune Deficiency Syndromes

Volumn 25, Issue 4, 2000, Pages 296-305

  Tortajada, Cecilia ^a,b   Garcia, Felipe ^a   Plana, Montserrat ^a   Gallart, Teresa ^a   Maleno, María Jose ^a   Miró, Jose María ^a   Gatell, Jose María ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

HAART; Immune restoration; Lymphoproliferative response; T cell markers

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANTIGEN EXPRESSION; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL ARTICLE; EFFECTOR CELL; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOREACTIVITY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALE; MEMORY CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

EID: 0034494087     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200012010-00002     Document Type: Article

References (29)

1. Toward an understanding of the correlates of protective immunity to HIV infection
2. HIV pathogenesis and long-term survival
3. + memory T cells by human immunodeficiency virus type 1: Evidence for a role in the selective T-cell function defects observed in infected individuals
4. Patterns of virus burden and T cell phenotype are established early and are correlated with rate of disease progression in human immunodeficiency virus type-1-infected persons
5. + T cell repertoire that are not immediately restored by antiviral or immune-based therapies
6. Alterations in the immune response of human immunodeficiency virus-infected subjects treated with an HIV specific protease inhibitor, Ritonavir
7. + T cell homeotasis and function in advanced HIV disease
8. Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease
9. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferation
10. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir
11. Recovery of the immune system with antiretroviral therapy
12. Long-term evaluation of T-cell subsets and T-cell function after HAART in advanced stage HIV-1 disease
13. Immune restoration does not always invariably occur following long-term HIV-1 suppression during antiretroviral therapy
14. Highly active antiretroviral therapy during early HIV infection reverses T-cell activation and maturation abnormalities
15. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic HIV-1 infection
16. CD8 naive T Cell counts decreased progressively in HIV-infected adults
17. The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: Staging and prognostic value
18. + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression
19. Correlation of CD8 lymphocyte activation with cellular viremia and HIV RNA plasma levels in asymptomatic patients infected by human immunodeficiency virus type 1
20. CD28 interaction with B7 costimulates primary allogenic proliferative response and cytotoxicity mediated by small, resting T lymphocytes
21. Expression of CD28 on CD8 and CD4 lymphocytes during HIV infection
22. Expression of costimulatory molecule CD28 on T cells in human immunodeficiency type I infection: Functional and clinical correlations
23. + T cells
24. + T cell apoptosis in patients with acute herpesvirus infection: Loss of costimulatory molecules CD28, CD5 and CD6 but relative maintenance of Bax and Bcl-X expression
25. - T cells to CD3 lymphocyte homeostasis during the natural course of HIV-1 infection
26. - lymphocytes in human immunodeficiency virus-specific cytotoxic activity
27. Lack of T-cell proliferative response to HIV-1 antigens after 1 year of highly active antiretroviral treatment in early HIV-1 disease. Immunology study group of Spanish EARTH-1
28. A randomized study comparing triple versus double therapy antiretroviral therapy or no treatment in HIV-1 infected patients in very early stage disease: The Spanish Earth-1 study